Workday, Inc. Free cash flow increased by 121.5% to $1.22B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.7%, from $1.03B to $1.22B. Over 3 years (FY 2022 to FY 2025), Free cash flow shows an upward trend with a 29.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $323.25M | $323.25M | $323.25M | $323.25M | $218.00M | $360.00M | $391.00M | $948.00M | $291.00M | $516.00M | $359.00M | $1.03B | $421.00M | $588.00M | $550.00M | $1.22B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -32.6% | +65.1% | +8.6% | +142.5% | -69.3% | +77.3% | -30.4% | +185.8% | -59.0% | +39.7% | -6.5% | +121.5% |
| YoY Change | — | — | — | — | -32.6% | +11.4% | +21.0% | +193.3% | +33.5% | +43.3% | -8.2% | +8.2% | +44.7% | +14.0% | +53.2% | +18.7% |